Gopestetika - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 380,244 | 761,247 | 762,941 | 913,812 | 994,284 | 911,591 | 1,001,275 | 955,215 |
| Profit before tax | 45,197 | 19,900 | 42,310 | 13,339 | -8,084 | -11,402 | 9,895 | 9,823 |
| Net profit | 38,058 | 15,414 | 35,814 | 11,252 | -8,084 | -11,402 | 9,442 | 9,367 |
| Equity | 25,366 | 43,280 | 79,028 | 90,280 | 82,196 | 70,794 | 90,436 | 99,803 |
| Liabilities | - | - | 61,029 | 126,975 | 147,946 | 172,008 | 180,251 | 188,241 |
| Non-current assets | 717 | 38,330 | 44,310 | 72,555 | 90,204 | 62,671 | 79,142 | 65,257 |
| Current assets | 81,450 | 90,436 | 90,811 | 134,357 | 133,268 | 174,681 | 186,990 | 218,490 |
| Total assets | 82,167 | 128,766 | 135,121 | 206,912 | 223,472 | 237,352 | 266,132 | 283,747 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 139,551 | 163,212 | 162,467 |
| Social insurance contributions | - | - | - | - | - | 36,089 | 37,472 | 37,824 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +957.3% | +100.2% | +0.2% | +19.8% | +8.8% | -8.3% | +9.8% | -4.6% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 46.3% | 12.0% | 26.5% | 5.4% | -3.6% | -4.8% | 3.5% | 3.3% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 150.0% | 35.6% | 45.3% | 12.5% | -9.8% | -16.1% | 10.4% | 9.4% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 10.0% | 2.0% | 4.7% | 1.2% | -0.8% | -1.3% | 0.9% | 1.0% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 11.9% | 2.6% | 5.5% | 1.5% | -0.8% | -1.3% | 1.0% | 1.0% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | - | 0.8 | 1.4 | 1.8 | 2.4 | 2.0 | 1.9 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 142,590 | 136,344 | 94,385 | 101,535 | 100,264 | 91,925 | 100,128 | 101,438 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Gopestetika - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2023-07-19 | 2023-07-20 | 891.97 |
Gopestetika - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2025-07-28 | 2025-07-28 | 2982.05 |
| 2025-04-28 | 2025-04-28 | 3830.69 |
| 2024-11-01 | 2024-11-18 | 12.04 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Gopestetika, UAB (code 304552180) is a Private Limited Liability Company engaged in the retail sale of other medical and orthopaedic goods. In the latest financial year, 2025, the company generated revenue of €955.2K, down 4.6% year on year after reaching €1.00M in 2024, but still above the €911.6K recorded in 2023. Profitability remained positive in 2025, with net profit of €9.4K and a profit margin of 1.0%, broadly unchanged from 2024 and a clear improvement from the €11.4K loss in 2023. Over the three-year period, the business moved from a loss to modest profit while maintaining relatively stable turnover.
Balance sheet strength increased gradually. Total assets rose to €283.7K in 2025 from €266.1K in 2024 and €237.4K in 2023. Equity increased to €99.8K, while liabilities stood at €188.2K. The equity ratio was 35.2% and debt-to-equity 1.89. Asset turnover reached 3.37x, showing efficient use of assets. Return on equity was 9.4% and return on assets 3.3%. Revenue per employee was €106.1K, while profit per employee was €1.0K.
Balance sheet strength increased gradually. Total assets rose to €283.7K in 2025 from €266.1K in 2024 and €237.4K in 2023. Equity increased to €99.8K, while liabilities stood at €188.2K. The equity ratio was 35.2% and debt-to-equity 1.89. Asset turnover reached 3.37x, showing efficient use of assets. Return on equity was 9.4% and return on assets 3.3%. Revenue per employee was €106.1K, while profit per employee was €1.0K.